This company has been marked as potentially delisted and may not be actively trading. OptiNose (OPTN) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock OptiNose Short Interest DataOptiNose (OPTN) has a short interest of 132,700 shares, representing 1.68% of the float (the number of shares available for trading by the public). This marks a -6.68% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 63,682 shares to cover all short positions.Current Short Interest132,700 sharesPrevious Short Interest142,200 sharesChange Vs. Previous Month-6.68%Dollar Volume Sold Short$1.24 millionShort Interest Ratio1.5 Days to CoverLast Record DateApril 30, 2025Outstanding Shares10,127,000 sharesFloat Size7,910,000 sharesShort Percent of Float1.68%Today's Trading Volume0 sharesAverage Trading Volume63,682 sharesToday's Volume Vs. Average0% Short Selling OptiNose? Sign up to receive the latest short interest report for OptiNose and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOPTN Short Interest Over TimeOPTN Days to Cover Over TimeOPTN Percentage of Float Shorted Over Time OptiNose Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025132,700 shares $1.24 million -6.7%1.7%1.5 $9.32 4/15/2025142,200 shares $1.31 million -25.8%1.8%1.5 $9.19 3/31/2025191,700 shares $1.76 million -29.5%2.4%2.1 $9.17 3/15/2025271,800 shares $1.46 million +11.8%3.4%3.5 $5.36 2/28/2025243,100 shares $1.41 million +0.9%3.1%6 $5.81 2/15/2025241,000 shares $1.45 million -2.7%3.0%5 $6.00 1/31/2025247,800 shares $1.47 million +16.2%3.1%3.8 $5.92 1/15/2025213,300 shares $1.28 million -30.0%2.7%3.3 $6.00 12/31/2024304,600 shares $2.03 million -90.5%3.8%5.5 $6.68 12/15/20243,190,000 shares $1.50 million -56.7%N/A4.2 $0.47 Get the Latest News and Ratings for OPTN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. 11/30/20247,360,000 shares $3.68 million -18.9%N/A9.7 $0.50 11/15/20249,070,000 shares $3.95 million +5.8%N/A13.8 $0.44 10/31/20248,570,000 shares $5.91 million -1.4%N/A25.5 $0.69 10/15/20248,690,000 shares $6.11 million +3.1%N/A20.8 $0.70 9/30/20248,430,000 shares $5.65 million +21.1%N/A16.2 $0.67 9/15/20246,960,000 shares $6.30 million -0.7%N/A9.6 $0.91 8/31/20247,010,000 shares $7.29 million +0.7%N/A9.7 $1.04 8/15/20246,960,000 shares $6.40 million +8.1%N/A9.4 $0.92 7/31/20246,440,000 shares $6.76 million +13.0%N/A7.8 $1.05 7/15/20245,700,000 shares $7.24 million -26.2%N/A4.5 $1.27 6/30/20247,720,000 shares $8.03 million +35.4%N/A6.3 $1.04 6/15/20245,700,000 shares $6.58 million -19.4%N/A5.3 $1.16 5/31/20247,070,000 shares $7.64 million -3.0%N/A6 $1.08 5/15/20247,290,000 shares $8.64 million +23.1%N/A6.1 $1.19 4/30/20245,920,000 shares $4.86 million +84.4%N/A5.2 $0.82 4/15/20243,210,000 shares $3.82 million +3.2%N/A5.3 $1.19 3/31/20243,110,000 shares $4.54 million -2.8%N/A5.7 $1.46 3/15/20243,200,000 shares $5.98 million -0.3%N/A5.9 $1.87 2/29/20243,210,000 shares $5.71 million -10.8%N/A8.5 $1.78 2/15/20243,600,000 shares $4.86 million +5.9%N/A10.1 $1.35 1/31/20243,400,000 shares $4.28 million -2.9%N/A10.8 $1.26 1/15/20243,500,000 shares $4.45 million -4.6%N/A11.4 $1.27 12/31/20233,670,000 shares $4.73 million -1.1%N/A11.5 $1.29 12/15/20233,710,000 shares $4.30 million +1.1%N/A11.9 $1.16 11/30/20233,670,000 shares $4.59 million -1.9%N/A11.6 $1.25 11/15/20233,740,000 shares $4.64 million -1.8%N/A14 $1.24 10/31/20233,810,000 shares $4.31 million +1.1%N/A12.6 $1.13 10/15/20233,770,000 shares $4.67 million -2.3%N/A12 $1.24 9/30/20233,860,000 shares $4.75 million -15.2%N/A10.8 $1.23 9/15/20234,550,000 shares $6.23 million +23.3%N/A11.4 $1.37When the levee breaks (Ad)The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.Click here to watch the urgent broadcast and get ahead of what’s coming. 8/31/20233,690,000 shares $4.39 million -3.2%N/A6.3 $1.19 8/15/20233,810,000 shares $4.72 million No ChangeN/A5.7 $1.24 7/31/20233,810,000 shares $4.59 million -16.6%N/A5.6 $1.21 7/15/20234,570,000 shares $4.34 million +24.9%N/A7.1 $0.95 6/30/20233,660,000 shares $4.50 million +53.8%N/A6.3 $1.23 6/15/20232,380,000 shares $2.69 million -0.4%N/A4.5 $1.13 5/31/20232,390,000 shares $2.99 million -0.8%N/A7.8 $1.25 5/15/20232,410,000 shares $4.70 million -1.2%N/A10.3 $1.95 4/30/20232,440,000 shares $4.17 million -3.6%N/A16.2 $1.71 4/15/20232,530,000 shares $4.81 million -2.3%N/A16 $1.90 3/31/20232,590,000 shares $5.00 million +4.9%N/A16.6 $1.93 3/15/20232,470,000 shares $4.47 million -2.8%N/A16.3 $1.81 2/28/20232,540,000 shares $4.57 million +0.8%4.9%12.9 $1.80 2/15/20232,520,000 shares $4.33 million -4.2%4.9%12.2 $1.72 1/31/20232,630,000 shares $4.71 million -4.7%N/A11.4 $1.79 1/15/20232,760,000 shares $4.97 million +6.2%N/A13.2 $1.80 12/30/20222,600,000 shares $4.81 million -5.8%N/A12.5 $1.85 12/15/20222,760,000 shares $4.83 million +16.0%N/A13.4 $1.75 11/30/20222,380,000 shares $4.21 million -4.8%N/A11.9 $1.77 11/15/20222,500,000 shares $4.63 million -5.7%N/A17.1 $1.85 10/31/20222,650,000 shares $9.25 million +1.9%5.3%23.2 $3.49 10/15/20222,600,000 shares $8.63 million +2.0%5.2%19.8 $3.32 9/30/20222,550,000 shares $9.33 million +23.2%5.1%19.2 $3.66 9/15/20222,070,000 shares $7.35 million -0.5%4.1%13.5 $3.55 8/31/20222,080,000 shares $7.59 million +1.0%4.2%8.6 $3.65 8/15/20222,060,000 shares $8.05 million -1.0%4.1%8.5 $3.91 7/31/20222,080,000 shares $7.53 million No Change4.2%8.7 $3.62 7/15/20222,080,000 shares $7.47 million -3.3%4.7%9 $3.59 6/30/20222,150,000 shares $7.87 million +2.4%4.8%9.1 $3.66 6/15/20222,100,000 shares $7.31 million +6.1%4.7%9.1 $3.48 5/31/20221,980,000 shares $4.08 million -1.0%4.5%9 $2.06 5/15/20222,000,000 shares $3.62 million -19.0%4.5%7.4 $1.81 4/30/20222,470,000 shares $5.98 million +0.4%5.6%8.3 $2.42 4/15/20222,460,000 shares $6.25 million -3.5%5.5%7.5 $2.54 3/31/20222,550,000 shares $6.30 million +16.4%5.9%6.8 $2.47 3/15/20222,190,000 shares $4.60 million +21.0%5.1%5.5 $2.10 2/28/20221,810,000 shares $5.30 million -14.2%4.4%4.9 $2.93 2/15/20222,110,000 shares $5.68 million +1.9%5.1%5.7 $2.69 1/31/20222,070,000 shares $4.76 million -6.8%5.0%4 $2.30 1/15/20222,220,000 shares $4.64 million -4.3%5.0%4.6 $2.09 12/31/20212,320,000 shares $3.76 million -7.2%5.2%5.3 $1.62 12/15/20212,500,000 shares $4.18 million -1.6%5.6%6 $1.67 11/30/20212,540,000 shares $4.04 million -10.9%8.7%6.6 $1.59 11/15/20212,850,000 shares $6.81 million +0.4%6.0%8 $2.39 10/29/20212,840,000 shares $7.53 million +3.7%8.8%13.4 $2.65 10/15/20212,740,000 shares $8.22 million -10.2%8.5%11.5 $3.00 9/30/20213,050,000 shares $9.15 million -3.2%9.5%10.8 $3.00 9/15/20213,150,000 shares $8.79 million +5.7%9.8%8.1 $2.79 8/31/20212,980,000 shares $8.67 million -24.8%9.1%7.5 $2.91 8/13/20213,960,000 shares $10.41 million -7.5%12.1%10.1 $2.63Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 7/30/20214,280,000 shares $12.16 million +2.6%13.1%11.4 $2.84 7/15/20214,170,000 shares $12.51 million +2.2%13.6%11 $3.00 6/30/20214,080,000 shares $12.69 million -19.8%13.3%11.3 $3.11 6/15/20215,090,000 shares $19.09 million -2.3%16.6%17.9 $3.75 5/28/20215,210,000 shares $16.62 million +3.2%17.0%17.2 $3.19 5/14/20215,050,000 shares $15.76 million +5.4%16.4%13.5 $3.12 4/30/20214,790,000 shares $17.82 million +7.4%15.6%11.2 $3.72 4/15/20214,460,000 shares $15.92 million +4.2%15.1%10 $3.57 3/31/20214,280,000 shares $15.02 million -0.5%14.5%9.4 $3.51 3/15/20214,300,000 shares $16.51 million -10.0%14.8%8.5 $3.84 2/26/20214,780,000 shares $19.22 million +1.3%16.2%9.5 $4.02 2/12/20214,720,000 shares $21.95 million +33.3%16.3%9.9 $4.65 1/29/20213,540,000 shares $14.37 million -34.6%12.2%7.6 $4.06 1/15/20215,410,000 shares $22.94 million +1.1%18.0%11.8 $4.24 12/31/20205,350,000 shares $22.36 million -23.6%17.8%12.8 $4.18 12/15/20207,000,000 shares $30.38 million +2.8%23.2%16.7 $4.34 11/30/20206,810,000 shares $29.08 million +23.4%22.5%17.9 $4.27 11/15/20205,520,000 shares $21.97 million -19.1%18.2%14.6 $3.98 10/30/20206,820,000 shares $22.85 million +1.8%22.4%16.6 $3.35 10/15/20206,700,000 shares $25.73 million -3.3%22.1%15.9 $3.84 9/30/20206,930,000 shares $27.03 million -7.7%22.8%14.3 $3.90 9/15/20207,510,000 shares $34.02 million -1.7%24.7%10.7 $4.53 8/31/20207,640,000 shares $34.76 million +15.1%25.1%11.3 $4.55 8/14/20206,640,000 shares $35.19 million -11.5%27.3%10.2 $5.30 OPTN Short Interest - Frequently Asked Questions What is OptiNose's current short interest? Short interest is the volume of OptiNose shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 132,700 shares of OPTN short. 1.68% of OptiNose's shares are currently sold short. Learn More on OptiNose's current short interest. What is a good short interest ratio for OptiNose? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OPTN shares currently have a short interest ratio of 2.0. Learn More on OptiNose's short interest ratio. What is a good short interest percentage for OptiNose? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.68% of OptiNose's floating shares are currently sold short. Is OptiNose's short interest increasing or decreasing? OptiNose saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 132,700 shares, a drop of 6.7% from the previous total of 142,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is OptiNose's float size? OptiNose currently has issued a total of 10,127,000 shares. Some of OptiNose's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OptiNose currently has a public float of 7,910,000 shares. How does OptiNose's short interest compare to its competitors? 1.68% of OptiNose's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to OptiNose: Tectonic Therapeutic, Inc. (18.11%), iTeos Therapeutics, Inc. (8.02%), Vigil Neuroscience, Inc. (1.40%), Aquestive Therapeutics, Inc. (10.08%), Eton Pharmaceuticals, Inc. (13.30%), Astria Therapeutics, Inc. (6.78%), Fulcrum Therapeutics, Inc. (9.10%), Prothena Corporation plc (11.25%), Olema Pharmaceuticals, Inc. (11.17%), CryoPort, Inc. (5.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Corporation ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short OptiNose stock? Short selling OPTN is an investing strategy that aims to generate trading profit from OptiNose as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OptiNose? A short squeeze for OptiNose occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OPTN, which in turn drives the price of the stock up even further. How often is OptiNose's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPTN, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Tectonic Therapeutic Short Interest iTeos Therapeutics Short Interest Vigil Neuroscience Short Interest Aquestive Therapeutics Short Interest Eton Pharmaceuticals Short Interest Astria Therapeutics Short Interest Fulcrum Therapeutics Short Interest Prothena Short Interest Olema Pharmaceuticals Short Interest CryoPort Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OPTN) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiNose, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiNose With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
